- Dell gifts push UT Austin support past $1B, fund new medical campus
- Hospital telehealth adoption by state
- CMS pauses weight-loss BALANCE model for Medicare
- Mayo Clinic backs virtual biomarker startup in $4.9M investment
- CMS to require state audits of all providers accepting Medicaid
- Texas ASC completes 1st artery embolizations with Regent Surgical platform
- Why independent dentistry is ready for a comeback
- UnitedHealthcare’s ‘deliberate trade-off’ for margin recovery
- Surgeons’ sex ruled out as driver of disparities in cardiac surgery: Study
- VCU Health creates new marketing leadership role
- Optum revenue hits $63.7B in Q1
- Wellstar CEO: Keeping care local while building across the Southeast
- What is ibogaine? 4 things to know
- Lexington Health names new CIO
- How Tenet turned a hospital company into the country’s largest ASC operator: 7 things to know
- What dentists need to know about the growing use of AI in healthcare
- 3 GI leaders keeping their practices independent in 2026
- 69% of DSOs plan to boost acquisitions in 2026: Report
- Minnesota ASC sees 1st Vanquish procedure in Midwest
- NADP appoints 1st dentist to permanent position
- Texas behavioral health provider reports breach affecting 285,000
- 5 new workforce statistics for dentists to know
- Heartland Dental to open $660K Florida office
- Heartland Dental adds RCM solutions to network
- Physician Partners of America adds another anesthesiologist
- Nonprofits to merge into national suicide prevention organization
- Prenatal medications linked to increased autism risk: 4 study notes
- What’s new with Ascension?
- Psych hospital’s security change draws scrutiny amid patient assaults
- 5 orthopedic leaders shaping ASC growth
- What 3 recent CON debates mean for the ASC industry
- The DSO de novo boom
- Children’s Activity Cubes Recalled Over Choking Hazard Risk
- What is ibogaine? 4 things to know
- Merck amps up presence in HIV treatment market with FDA nod for novel combo pill Idvynso
- Rush to open 60,000-square-foot Chicago wellness center
- 'Don't be a wimp,' Mark Cuban tells lawmakers hesitant to break up PBMs
- VideaHealth undergoes rebrand, extends to private practices
- Study Finds AI Chatbots Can Give Misleading Health Advice
- Former Surgeon General Backs CDC Nominee, But Questions Remain on Vaccines
- Listen to the Latest ‘KFF Health News Minute’
- Cantaloupes Recalled in Four States Due to Salmonella Risk
- Keynote Remarks at The Economic Club of Washington
- Merger to create nation's largest suicide prevention nonprofit
- Oz previews new plan to push states toward revalidating Medicaid providers
- Pfizer's strategy head Andrew Baum to step down following brief tenure: reports
- Covera Health, Medmo combine to create end-to-end diagnostic imaging platform
- The Oral GLP-1 Tracker: Following the launch trajectories of Lilly’s Foundayo, Novo’s Wegovy pill
- Service Dogs Perform Tasks Akin To Human Caregivers, Researchers Say
- A Third Of Young Adults Are Couch Potatoes, Their Parents Say
- Powerful Antibiotic Combo Not Necessary For Simple Sinus Infections, Study Shows
- Black Women Hit Hardest By Pandemic-Related Rise In Pregnancy-Related Deaths
- Smoking, Vaping Weed Increases Risk Of Asthma Attacks Among Young Adults, Study Finds
- Less-Dangerous Painkillers, Gabapentinoids, Still Have High Risk For Drug Interactions
- AstraZeneca eyes 5th Ultomiris indication after kidney disease trial win
- In a Merck Litespark shocker, Welireg triplet misses the mark in first-line kidney cancer
- Real Estate Investors Profit From Long-Term Care While Residents Languish
- Democrats Demand Trump Administration Halt Plan To Collect Federal Workers’ Health Data
- Listen: Cheap Health Insurance Isn’t Always Cheap
- UnitedHealth Group spotlights AI investments as part of operational turnaround
- ECRI spins out healthcare supply chain division into Staritas, backed by PE firm Accel-KKR
- UCB partners with Myasthenia Gravis Foundation of America on meal program targeting nutrition deserts
- Indiana University Southeast earns counseling accreditation
- Ohio safety-net provider to acquire behavioral health organization
- Replimune ramps up layoffs to cover 60% of workforce amid ongoing fallout of FDA rejection
- Connecticut dentists among growing number of non-hospital clinicians suing patients over medical debt: Report
- 3 in 10 adults turn to digital tools for mental health: 4 study notes
- Statement on the Amendments to Form PF
- Update on the SEC’s Work Toward Treasury Clearing Implementation
- 'Hospitals adverse to transparency'—clashing industry groups spar on mulligan 340B rebate pilot
- San Diego County opens $28M crisis stabilization unit
- “PF” Stands for Please Fix: Statement on the Proposed Amendments to Form PF
- A look inside Highmark and Spring Health's mental well-being partnership
- CVS, Mass General Brigham primary care deal would increase annual care spending by $40M, report predicts
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Beyond Reporting: Realizing Continuous Safety Surveillance for Medical Devices
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- Safeguarding Scientific Publishing from AI Hallucinations and Fabricated Citations
- AIDS Relief Program Sees Drops in Testing and Diagnoses After Disruptions
- Baby Food Recalled After Rat Poison Discovered in Jar
- Report Finds Drug Prices Rising Despite Trump Pricing Deals
- Trump Backs Psychedelic Research
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition
- Hippocratic AI rolls out 2 new tools aimed at expanding clinical access, improving nurse workflow
- In Connecticut, doctors now sue patients most over medical bills, surpassing hospitals
- Sanofi touts tolerability of COVID shot Nuvaxovid in head-to-head trial vs. Moderna's mNexspike
- Physician burnout falls for third year in 2025 to 42%, AMA data shows
- Naloxone's OD-Reversing Powers Challenged By Today's Opioids, Tests Show
- Extra Antibiotic Doesn't Reduce Infection Risk During Surgery To Fix Complex Fractures, Trial Finds
- Clinical Trial Suggests Two Simple Ways To Fight Chemo-Related Brain Fog
- E-Cigarette Taxes Won't Necessarily Cause An Increase In Smoking, Study Says
- Dreams Affect Your Morning Mood In Surprising Ways, Study Finds
- Weed Blunts Brain Development In Teens
- Genentech shifts Hemlibra marketing focus to patient stories as competition approaches
- An Arm and a Leg: The Accidental Architect of America’s Drug Patent Problem
- In Connecticut, Doctors Now Sue Patients Most Over Medical Bills, Surpassing Hospitals
- Neurogene hires new CCO as it eyes commercial future for its Rett gene therapy
- Biovac nets $108M finance package to build Africa’s first fully integrated vaccine plant
- Theramex exits self-regulatory body after ‘systemic’ compliance failures
- Trump orders FDA to fast-track reviews of psychedelic drugs after lobbying by podcaster
- Bayer falls short in bid to block J&J’s survival claims in prostate cancer clash
- Biogen bullish on America with Durham Bulls team up
- AbbVie launches ‘PSO Done’ psoriasis campaign with cross-agency effort
- DOJ seeks immediate asset freeze, receivership against telehealth company Zealthy
- New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer
- Does My Child Have a Language Disorder?
- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
- AACR: FDA vet Pazdur bemoans state of agency, warns of political influence and ‘sense of anxiety’
- Tu nuevo terapeuta: conversador, indiscreto… y difícilmente humano
- What the Health? From KFF Health News: A New CDC Nominee, Again
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care
- Oscar unveils Lucie, its one-stop shop for individual market plans, supplemental benefits
- Affordability, transparency: A look at large employers' top healthcare concerns
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Trump Names CDC Director Pick
- SocialRx teams up with FQHC in NYC to prescribe arts and culture for chronically ill patients
- FDA To Review Whether To Allow More Access To Certain Peptides
- Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Over 80% of PCPs concerned about financial stability over next several years
- Industry Voices—DOJ jumps into 340B cases over state law, raising questions about federal plans for the program
- FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER
- Most People Would Take A Blood Test For Alzheimer's, Study Says
- This Sexually Transmitted Infection Linked To Heart Attack, Stroke
- How Playtime at Age 2, Especially with Parents, Shapes Teen Fitness Habits
- New Depression Treatment Matches ECT with Less Memory Loss, Study Says
- Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says
- Ultra-Processed Foods Linked To Fatty Muscles, Potential Knee Arthritis
- Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
- Gen AI chatbots continually struggle with differential diagnoses, Mass General Brigham study finds
- Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale
- Remarks at the Options Market Structure Roundtable
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- Cattywampus: Statement on the CAT Concept Release
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Beyond the Visit: How AI Companion Technology Is Reshaping Outcomes for Aging Populations
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Brain Cancer Awareness: The Importance of Molecular Testing for Patients with Rare Brain Tumors
- AI simulates real-world HCP feedback on pharma content
Generic left wing, health care, and pharmaceutical groups are coalescing into a political bloc which vows to derail the nomination of Robert F. Kennedy Jr. as the next Health & Human Services Secretary:
Kennedy opposed by advocates for US health post
By Michael Erman and Julie Steenhuysen - December 16, 2024Summary
* Coalition of 40+ groups opposes Kennedy's HHS nomination
* Groups are concerned about Kennedy's potential vaccine policies
* Advocates target Republican senators to block confirmationDec 16 (Reuters) - An expanding coalition of health and consumer advocates is campaigning against Robert F. Kennedy Jr.'s nomination to the top U.S. health job over concerns about his activism against vaccines and other health issues, according to the groups' representatives.
Obamacare advocate Protect Our Care, influential consumer group Public Citizen and Community Catalyst, which fights for equality in healthcare, are part of a coalition of at least 40 organizations targeting a group of Republican U.S. senators to help block Kennedy's confirmation as U.S. Secretary of Health and Human Services.
The Committee to Protect Health Care, a grassroots physician organization, has also amassed nearly 16,000 signatures from physicians who oppose Kennedy's nomination.
The efforts come as Kennedy heads to Capitol Hill to win support following his nomination by President-elect Donald Trump including by meeting with incoming Senate health committee chairman Republican Bill Cassidy, a Cassidy staff member confirmed.
"We’re going to work to block his nomination. And I think we will succeed," said Peter Maybarduk, access to medicines director of Public Citizen, a consumer group founded by Ralph Nader in 1971, which has worked for causes including drug safety and airbags in cars. "Even if RFK Jr. can't amass the power to take down vaccine funding, elevating his falsehoods to some kind of officialdom is a danger all its own."
Kennedy has long sown doubts about the safety and efficacy of vaccines that have helped curb disease and prevent deaths for decades. He disputes the anti-vaccine label and has said he would not prevent Americans from getting inoculations, but is a founder of the anti-vaccine group Children's Health Defense and in a 2023 interview with Lex Fridman said no vaccines are safe and effective.
Kennedy has said he wants to work to end chronic disease, break any ties between employees at the U.S. drugs regulator and industry, and advise U.S. water systems to remove fluoride. Trump has said he will discuss the U.S. childhood vaccination program with Kennedy, and on Monday said all vaccines should be looked at.
Kennedy's spokesperson did not respond to a request for comment. His advocates have said opposition to his nomination stems from corporate interests.
Protect Our Care Executive Director Brad Woodhouse said the group has hired lobbying and advocacy teams in more than six states to try to win over the Republican senators seen as possible "no" votes given their track records on health issues or because they are likely to face strong 2026 reelection challenges.
The groups are also raising money to buy ads and conduct polling on health issues, they said.
Protect Our Care, which works to defend the Affordable Care Act, said it will likely hold media briefings with public health experts and politicians to call attention to Kennedy's policies as he meets with senators.
Others have opposed the nomination as well. Pfizer board member Scott Gottlieb, a former FDA commissioner under Trump, told CNBC last month Kennedy's agenda "will cost lives in this country." The Wall Street Journal's Editorial Board in a Dec. 4 column wrote that Kennedy could "disrupt access to life-saving medicines and the innovation ecosystem that creates them."
HHS has oversight for the FDA, the Centers for Disease Control and Prevention and the National Institutes of Health.
TARGETING SENATORS
Confirmation of Kennedy and other cabinet nominees requires a majority vote in the Senate. Kennedy needs the backing of 50 out of the 53 Republican senators if all 47 Democrats vote against him. The advocates are targeting senators in states including Alaska, Idaho, North Carolina, Iowa, West Virginia and Maine.
American Values 2024, a Super PAC that supports Kennedy, has initiated a video campaign defending the nominee.
In a video it posted on social media platform X, Jay Carson, who used to work for President Bill Clinton and other Democrats but now supports Kennedy, argues that opposition to Kennedy stems from a smear campaign by pharmaceutical companies.
"They're determined to keep him out of Washington, D.C.," the Super PAC said on X.
The top lobby group for drugmakers, Pharmaceutical Research and Manufacturers of America, declined to comment. In a Nov. 14 statement, the industry said it wants to work with the Trump administration.
Community Catalyst, which has raised millions since 1998 to support equal access to healthcare, said Kennedy's anti-vaccine rhetoric and position against fluoridated water pushed it to act.
Mona Shah, Community Catalyst's senior director of policy and strategy, said the group has worked for decades to improve dental care access in hard-to-reach communities that face racial discrimination where removing fluoride from drinking water could do the greatest harm.
"We really feel that some of these policies would hurt communities, really endanger children and families and truly make us sicker as a nation," Shah said.
The Committee to Protect Health Care's petition describes Kennedy's appointment as a threat to patient safety and "an affront" to public health. The group accepts no pharmaceutical industry funding.
Dr. Rob Davidson, the group's executive director and an emergency room physician in Michigan, said Americans need to be aware of Kennedy's "very dangerous" positions on topics like vaccines, and COVID-19 being engineered to target certain racial populations.
"We want to make sure people understand he's not just a kooky guy who says weird things," Davidson said.
More:
https://www.politico.com/live-updates/2024/12/16/congress/rfk-jr-opponents-buy-ads-00194493
RFK Jr. opponents buy ads in key senators’ states
By Daniel Payne - December 16, 2024Opponents of Robert F. Kennedy Jr.’s nomination to lead HHS are buying tens of thousands of dollars in ads across the states of key Republican senators as he plans to meet with them this week.
Protect Our Care, which has launched a Stop RFK War Room, has bought advertising slots — from digital ads to billboards — calling on constituents to urge their senators to oppose Kennedy’s nomination, leaders of the group told POLITICO.
“We’re going to accelerate our activity,” said Brad Woodhouse, executive director of Protect Our Care, a health advocacy group aligned with Democrats. “We think this week’s a big deal.”
The group is targeting GOP senators it believes could be persuaded to vote against Kennedy’s confirmation: Sens. Lisa Murkowski (R-Alaska), Mike Crapo (R-Idaho), Susan Collins (R-Maine), Bill Cassidy (R-La.), Thom Tillis (R-N.C.), Mike Rounds (R-S.D.), John Cornyn (R-Texas), Shelley Moore Capito (R-W.Va.) and the newly elected Jim Justice (R-W.Va.).
The ads connect Kennedy’s unsupported claims about the danger of vaccines to the deaths of more than 80 children during a measles outbreak in Samoa in 2019 — and argue that health professionals, scientists and the conservative Wall Street Journal editorial board oppose his confirmation, making it a safe position for Republicans.
Why it matters: Protect Our Care, along with several groups focused on public health, are arguing to senators — and the public — that Kennedy’s views on vaccines, medical authorities and key health policies would be detrimental to the U.S. population, should he lead HHS.
To block Kennedy, four Republican senators would have to oppose his confirmation if every Democrat votes no.
What’s next? Protect Our Care expects more campaigning against the nominee in the future.
“We will spend more,” Woodhouse said. “We’re just starting this process.”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














